Chicago, IL, United States of America

Zhiyu Chen

This inventor holds 1 USPTO granted patent. Top assignee: Smartcells, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhiyu Chen. Retrieved from https://idiyas.com/inventor/zhiyu-chen-3ezazp4x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhiyu Chen: Innovator in Drug-Ligand Conjugates

Introduction

Zhiyu Chen is a notable inventor based in Chicago, IL, who has made significant contributions to the field of pharmaceuticals. His work primarily focuses on the synthesis of drug-ligand conjugates, which are essential for developing effective therapeutic agents.

Latest Patents

Zhiyu Chen holds a patent for "Drug-ligand conjugates, synthesis thereof, and intermediates thereto." This invention relates to methods for synthesizing compounds of a specific formula, which are crucial for creating pharmaceutically acceptable salts. The detailed description of the compounds includes various components defined in the patent documentation.

Career Highlights

Chen is currently employed at Smartcells, Inc., where he applies his expertise in drug development and synthesis. His innovative approach has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Zhiyu Chen collaborates with esteemed colleagues such as Thomas M. Lancaster and Todd C. Zion, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Zhiyu Chen's work in drug-ligand conjugates exemplifies the impact of innovative thinking in the pharmaceutical sector. His contributions continue to advance the field and improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…